
Wildfire Smoke and Migraine: What a Million-Visit Study Found
Wildfire smoke was linked to about 6% more ER visits for migraine and headache.
What each study found, how strong the evidence is, and what it means for you. For the daily roundup of everything new, see Today in Migraine Science.

Wildfire smoke was linked to about 6% more ER visits for migraine and headache.

Sham-controlled trials show a modest benefit from acupuncture, on low-certainty evidence.

Real-world data on every-other-day rimegepant for prevention and why starting earlier helps.

About 1 in 9 people are pain-free at 2 hours on placebo, and that rate keeps rising.

In a one-year study of nearly 600 people on atogepant, average weight went down.

A large randomized trial found a personalized low-glycemic diet lowered monthly migraine days.

Real-world data show fremanezumab cut migraine days by nearly 6 a month.

Blood CGRP was lower in people with migraine, not higher, and did not track with attacks.

In 130,000 women, a migraine history was tied to modestly higher stroke risk after menopause.

Candesartan, a low-cost blood pressure pill, can prevent attacks. Dosing, safety and fit.

A review of 10,000 patients confirms a strong two-way link between migraine and jaw disorders.

A genetics study found FAAH gene changes in people with medication overuse headache.

A 2025 study found adults with acne had about 65% higher odds of migraine.

Real-world data on 14,285 patients found CGRP antibodies safe, with a few signals to watch.

Treating subclinical hypothyroidism with levothyroxine may reduce migraine frequency.

A trial tested fremanezumab (Ajovy) in people with both migraine and major depression.

Which patient traits predicted a good response to erenumab (Aimovig) in one study.

A three-year study suggests CGRP antibodies may change the course of migraine.